过去一年中添加的文章，按日期排序
Unraveling the Challenges in the Retinoid-related Orphan Receptor (ROR)-y (t) Therapeutic Landscape for Autoimmune Diseases
D Banerjee - Medical Research Archives, 2024 - esmed.org
42 天前 - … of several human immune-mediated diseases and remains … targeting IL-23, IL-17,
IL-17R, and other cytokines in the … therapeutics beyond a handful of autoimmune diseases, …
IL-17R, and other cytokines in the … therapeutics beyond a handful of autoimmune diseases, …
Paradoxical Psoriasis
M Abdelghaffar, S Kottilil, MJ Murphy… - Dermatologic …, 2024 - derm.theclinics.com
58 天前 - … including tumor necrosis factor-alpha (TNFα), IL-17 family members, IL-12/23p40,
IL-23-… of a pre-existing immune-mediated disorder after starting a cytokine blocking therapy. …
IL-23-… of a pre-existing immune-mediated disorder after starting a cytokine blocking therapy. …
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation
M Robert, P Miossec - Autoimmunity Reviews, 2024 - Elsevier
84 天前 - … current therapeutic strategy used in immune-mediated … This cytokine acts on Th17
differentiation and favors IL-17 A, IL-… We will focus on IL-17 A, IL-17F and IL-23 production, …
differentiation and favors IL-17 A, IL-… We will focus on IL-17 A, IL-17F and IL-23 production, …
[PDF][PDF] Recent Advances in the Diagnosis and Management of Psoriasis: A Comprehensive Review
P Singh, PK Rathore, A Singh - Recent Advances in the …, 2024 - scope-journal.com
99 天前 - … is a chronic immune-mediated inflammatory skin disorder … biologic therapies
targeting specific cytokines. Biologic agents such as TNFalpha inhibitors, IL-17 inhibitors, and IL-23 …
targeting specific cytokines. Biologic agents such as TNFalpha inhibitors, IL-17 inhibitors, and IL-23 …
Challenges in Immunomodulation for Psoriasis: Recent Advancements and Need of Therapies
D Singh - Current Drug Therapy, 2024 - ingentaconnect.com
109 天前 - … is a chronic immune-mediated skin disorder affecting millions … lies in the targeted
inhibition of key cytokines and … of interleukin-17 (IL-17) and interleukin-23 (IL-23) inhibitors has …
inhibition of key cytokines and … of interleukin-17 (IL-17) and interleukin-23 (IL-23) inhibitors has …
[HTML][HTML] Psoriasis Therapies in 2024 and Beyond
N Nicholas Brownstone - 2024 - dermatologytimes.com
142 天前 - … of the immune-mediated nature of … cytokines include TNF-α and IL-17. The fact
that biologic agents interact with a specific cytokine (such as TNF-α, IL-17, or IL-23) in a targeted …
that biologic agents interact with a specific cytokine (such as TNF-α, IL-17, or IL-23) in a targeted …
Targeting cyclin-dependent kinases in rheumatoid arthritis and psoriasis–a review of current evidence
M Staniszewska, K Kiełbowski, K Rusińska… - … Therapeutic Targets, 2023 - Taylor & Francis
218 天前 - … cytokines. Psoriasis is a chronic immune-mediated skin disease, and several
cytokines are … in the progression of the disease, including IL-23, IL-22, and IL-17, among others. …
cytokines are … in the progression of the disease, including IL-23, IL-22, and IL-17, among others. …